CLOs on the Move

Earlens

www.earlens.com

 
Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss. The company has developed the Earlens® Contact Hearing Solution, which directly vibrates the eardrum with a tiny lens in order to activate the natural hearing process. This revolutionary, nonsurgical hearing solution delivers the broadest bandwidth available today and superior sound quality. The Earlens® Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. We believe that people with hearing loss shouldn`t have to think about their hearing in everyday situations. Earlens was ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.earlens.com
  • 4045-A Campbell Avenue
    Menlo Park, CA USA 94025
  • Phone: 650.366.9000

Executives

Name Title Contact Details
Bernard Shay
 General Counsel Profile

Similar Companies

Surgipath Medical Industries

Surgipath Medical Industries is a worldwide leader in the development, manufacture and supply of quality product solutions for the Anatomical Pathology Laboratory. Since we were founded, our fundamental business strategies ensure our customer's

BioSig

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.

Laboratory Specialists

Laboratory Specialists is a Toledo, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scrip Companies

Scrip Companies is a Bolingbrook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Med Services

Med Services is a Bohemia, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.